Almudena Rubio
9Patents
2h-index
34Co-inventors
43Inventor score
Filing activity: Apr 13, 2016 → Mar 24, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10654866B2 | Selective estrogen receptor degraders | Human Necessities | 5 | Active |
| US9872853B2 | 2,3-dihydro-1H-indole compounds | Chemistry; Metallurgy | 2 | Active |
| US10759786B2 | 1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancer | Chemistry; Metallurgy | 2 | Active |
| US11117902B2 | Selective estrogen receptor degraders | Human Necessities | 2 | Active |
| US11634426B2 | Selective estrogen receptor degraders | Human Necessities | 1 | Active |
| US10093651B2 | Ghrelin O-acyl transferase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12351591B2 | KRas inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10227310B2 | Ghrelin 0-acyl transferase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11993608B2 | Selective estrogen receptor degraders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.